Viewing Study NCT00117156


Ignite Creation Date: 2025-12-24 @ 11:20 PM
Ignite Modification Date: 2026-01-17 @ 9:32 PM
Study NCT ID: NCT00117156
Status: COMPLETED
Last Update Posted: 2016-08-01
First Post: 2005-06-30
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Fludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkin's Lymphoma
Sponsor: Dana-Farber Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, Non-Hodgkin View
None MALT Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Fludarabine View
None Rituximab View
None Marginal Zone Lymphoma View
None MALT lymphoma View